Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to develop new treatments that will hopefully result in the
relief of symptoms and prolongation of life. For this reason, your doctors have offered you
treatment with a new experimental drug called PS 341.